{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:34:28Z","timestamp":1789043668770,"version":"build-2803163510"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016226","name":"Accuray","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose\/Objectives<\/jats:title><jats:p>The aim of this study is to report historical treatment planning experience at our institution for patients receiving total marrow and lymphatic irradiation (TMLI) as part of the conditioning regimen prior to hematopoietic stem cell transplant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials\/Methods<\/jats:title><jats:p>Based on a review of all historical clinical TMLI treatments plans, we retrieved a 12-Gy cohort of 108 patients with a prescription dose of 12 Gy to the skeletal bones, lymph nodes, spleen, and spinal canal, and retrieved a 20-Gy cohort of 120 patients with an escalated prescription dose of 20 Gy to the skeletal bones, lymph nodes, spleen, and spinal cord, and 12 Gy to the brain and liver. Representative dosimetric parameters including mean and median dose, D80, and D10 (dose covering 80% and 10% of the structure volume, respectively) for targets and normal organs were extracted and compared between the two groups of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>For the 12-Gy cohort, the average mean dose for normal organs ranged from 18.3% to 78.3% of 12 Gy, and the average median dose ranged from 18.3% to 77.5% of 12 Gy. For the 20-Gy cohort, the average mean dose for normal organs ranged from 13.0% to 76.0% of 20 Gy, and the average median dose ranged from 12.5% to 75.0% of 20 Gy. Compared to the mean dose to normal organs in the 12-Gy cohort, the average mean dose to normal organs increased from 0.0% to 73.1%, with only four normal organs showing a &amp;gt;50% increase. Normal organ dose in TMLI plans using volumetric modulated arc therapy fields fell within the dose range in historical TMLI plans.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Dosimetric data in historical TMLI plans at our institution are summarized at prescription dose levels of 12 Gy and 20 Gy, respectively. Compared to the normal organ dose with a prescription dose of 12 Gy, the mean and median dose to most normal organs at an escalated prescription dose of 20 Gy had an increase less than prescription dose scaling. Dosimetric results from this study can be used as reference data to facilitate clinical implementation of TMLI at other institutions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.946725","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T11:26:51Z","timestamp":1658834811000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Target Coverage and Normal Organ Sparing in Dose-Escalated Total Marrow and Lymphatic Irradiation: A Single-Institution Experience"],"prefix":"10.3389","volume":"12","author":[{"given":"Chunhui","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey Y.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(00)00333-9","article-title":"Total Body Irradiation-Based Regimen in the Conditioning of Patients Submitted to Haploidentical Stem Cell Transplantation","volume":"58","author":"Aristeri","year":"2001","journal-title":"Radiother Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.04.071","article-title":"Total Body Irradiation: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)","volume":"101","author":"Wong","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.12.029","article-title":"A Comparison of Cyclophosphamide and Total Body Irradiation With Etoposide and Total Body Irradiation as Conditioning Regimens for Patients Undergoing Sibling Allografting for Acute Lymphoblastic Leukemia in First or Second Complete Remission","volume":"12","author":"Marks","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.9.1867.1867","article-title":"Allogeneic Marrow Transplantation in Patients With Acute Myeloid Leukemia in First Remission: A Randomized Trial of Two Irradiation Regimens","volume":"76","author":"Clift","year":"1990","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.8.1660.1660","article-title":"Allogeneic Marrow Transplantation in Patients With Chronic Myeloid Leukemia in the Chronic Phase: A Randomized Trial of Two Irradiation Regimens","volume":"77","author":"Clift","year":"1991","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.4.1455","article-title":"Long-Term Follow-Up of a Randomized Trial of Two Irradiation Regimens for Patients Receiving Allogeneic Marrow Transplants During First Remission of Acute Myeloid Leukemia","volume":"92","author":"Clift","year":"1998","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1118\/1.2044428","article-title":"Feasibility Study of Helical Tomotherapy for Total Body or Total Marrow Irradiation","volume":"32","author":"Hui","year":"2005","journal-title":"Med Phys"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.10.026","article-title":"Targeted Total Marrow Irradiation Using Three-Dimensional Image-Guided Tomographic Intensity-Modulated Radiation Therapy: An Alternative to Standard Total Body Irradiation","volume":"12","author":"Wong","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.10.047","article-title":"Image-Guided Total Marrow and Total Lymphatic Irradiation Using Helical Tomotherapy","volume":"67","author":"Schultheiss","year":"2007","journal-title":"Int J Radiat Oncol Biol Phy"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/153303460600500508","article-title":"Linac-Based Intensity Modulated Total Marrow Irradiation (IM-TMI)","volume":"5","author":"Aydogan","year":"2006","journal-title":"Technol Canc Res Treat"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2011.06.005","article-title":"Dosimetric Study of Volumetric Modulated Arc Therapy Fields for Total Marrow Irradiation","volume":"102","author":"Han","year":"2012","journal-title":"Radiother Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.11.028","article-title":"Preclinical Assessment of Volumetric Modulated Arc Therapy for Total Marrow Irradiation","volume":"80","author":"Fogliata","year":"2011","journal-title":"Int J Radiat Oncol BiolPhys"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.03.033","article-title":"Dose Escalation of Total Marrow Irradiation With Concurrent Chemotherapy in Patients With Advanced Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation","volume":"85","author":"Wong","year":"2013","journal-title":"Int J Radiat Biol Phy"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.01.067","article-title":"Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients With Relapsed\/Refractory Acute Leukemia","volume":"23","author":"Stein","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.04.002","article-title":"Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation","volume":"23","author":"Hui","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.08.010","article-title":"Radiation-Related Toxicities Using Organ Sparing Total Marrow Irradiation Transplant Conditioning Regimens","volume":"105","author":"Shinde","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.02.034","article-title":"Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia is Associated With Inferior Survival: A Report From the Children\u2019s Oncology Group","volume":"104","author":"Esiashvili","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.946725\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T11:26:57Z","timestamp":1658834817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.946725\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":17,"alternative-id":["10.3389\/fonc.2022.946725"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.946725","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"article-number":"946725"}}